𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma : Frequency, associated tumor characteristics, and impact on prognosis

✍ Scribed by Shoji Natsugoe; James Mueller; Hubert J. Stein; Marcus Feith; Heinz Höfler; J. Rüdiger Siewert

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
678 KB
Volume
83
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

The purpose of this study was to investigate micrometastasis (MM) and tumor cell microinvolvement (TCM) in the regional lymph nodes of patients with esophageal squamous cell carcinoma (SCC).

METHODS.

MM was defined as individual tumor cells or tumor cell clusters Ͻ0.5 mm in greatest dimension with a surrounding stromal reaction. TCM was defined as individual tumor cells or tumor cell clusters without a surrounding stromal reaction. One thousand nine hundred and fifty-four lymph nodes were dissected from 69 complete (R0) resection specimens of TNM classified pT1-3, pN0 or pN1, and M0 esophageal SCC. These lymph nodes were examined immunohistochemically using the monoclonal antibody cocktail AE1/AE3 for cytokeratins. The primary tumors were immunostained with an anti-E-cadherin monoclonal antibody.

RESULTS.

MM Ϯ TCM was found in 13 cases (31.7%) and TCM alone in 2 cases (4.9%) of the 41 pN0 cases. The pN0 patients with MM (but not TCM) had the same shorter survival as the original pN1 cases (P Ͻ 0.05). Of the 69 primary tumors, 49 (71.0%) had reduced or negative E-cadherin expression that showed a correlation with the occurrence of lymph node metastases (original pN1), MM, and TCM, but not prognosis.

CONCLUSIONS.

The results of the current study show that, in SCC of the esophagus, MM, but not TCM, in the regional lymph nodes is prognostically equivalent to metastasis and should be examined by immunohistochemistry to classify these cases correctly as pN1.

📜 SIMILAR VOLUMES

Frequency and clinical impact of lymph n
Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction
✍ James D. Mueller; Hubert J. Stein; Tao Oyang; Shoji Natsugoe; Marcus Feith; Mart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

## BACKGROUND. Tumor involvement of regional lymph nodes has a crucial impact on the prognosis of patients with adenocarcinoma of the esophagogastric junction (AEG). Although additional tumor cell deposits can be detected by sensitive methods (e.g., immunohistochemistry and polymerase chain reacti

Neoadjuvant chemotherapy for patients wi
Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma : Effect on tumor cell microinvolvement of regional lymph nodes
✍ Karen Becker; Umberto Fumagalli; James D. Mueller; Ulrich Fink; J. Rüdiger Siewe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

## BACKGROUND. In a previous study the authors demonstrated, using immunohistochemical methods for epithelial antigens, that the regional lymph nodes of gastric adenocarcinoma contained individual tumor cells or small clusters of these cells (tumor cell microinvolvement [TCM]) in over 90% of cases

Characterization of p53 gene mutations i
Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: Increased frequency and different spectrum of mutations from primary tumors
✍ Hisashi Tanaka; Ichio Shibagaki; Yutaka Shimada; Takashi Wagata; Masayuki Imamur 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 557 KB

We screened 29 human esophageal squamous cell carcinoma (ESC) cell lines for mutations of the p53 gene through all coding exons and exon-intron junctions. Mutations were found in 22 cell lines (76%), consisting of 20 single-base substitutions, 2 small deletions and I single-base insertion. Out of 20

Prevalence and impact on clinicopatholog
Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma
✍ Daniel Weiss; Mario Koopmann; Claudia Rudack 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 3 views

## Abstract ## Background. Human papillomavirus (HPV) is a basic risk factor for head and neck squamous cell carcinoma (HNSCC). Little knowledge exists about the impact of HPV on clinical diagnostic and therapy of patients with HNSCC. ## Methods. We evaluated the evidence of HPV16 in 131 retrosp

High expression of EZH2 is associated wi
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
✍ Li-Ru He; Meng-Zhong Liu; Bin-Kui Li; Wei-Hua Jia; Ying Zhang; Yi-Ji Liao; Yang- 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 498 KB 👁 1 views

## Abstract The enhancer of zeste homolog 2 (EZH2), a known repressor of gene transcription, has been reported to be associated with biological malignancy in several cancers. The potential oncogenic role of EZH2 and its clinical/prognostic significance, however, in esophageal squamous cell carcinom